Clinical trial
Feasibility of Using a Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access
NCT03659552 is registered in ClinicalTrials.gov with Lungpacer Medical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Using a Percutaneous Temporary Placement of a Transvenous Phrenic Nerve Stimulator for Diaphragm Pacing Using Jugular Access
- Lead sponsor
- Lungpacer Medical Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 7, 2018
- Completion date
- August 30, 2018
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.